Fibroblastic reticular cells direct the initiation of T cell responses via CD44

The movement of dendritic cells and T cells within secondary lymphoid organs is critical for the development of adaptive immune responses<sup>1,2</sup>. Central to this process is the fibroblastic reticular cell (FRC) network, which forms a highly organized conduit system that facilitates the movement of and interactions between dendritic cells and T cells<sup>3-6</sup>. Previous studies have partly characterized how FRCs support these interactions<sup>7,8</sup>. However, the molecular mechanisms that operate under physiological conditions remain unknown. Here we show that the viral protein m11, encoded by the herpesvirus murine cytomegalovirus (CMV), inhibits antiviral immunity by targeting the FRC network and interfering with a critical function of cellular CD44. We found that m11 binds to CD44 and established that m11 perturbs the molecular interactions of CD44 with its natural ligand, hyaluronic acid. The interaction of m11 with CD44 impairs the trafficking of dendritic cells within the spleen, thereby impeding efficient priming of naive T cells and the initiation of antiviral CD8 T cell responses. The targeting of CD44 by CMV reveals CD44 as a molecule that is essential to the functioning of the FRC network and uncovers a previously unrecognized stroma-based mechanism that is critical for the generation of effective T cell responses.

Authors

Institutions

Publication Details

Journal
Nature
Published
2026-01-21
DOI
https://doi.org/10.1038/s41586-025-09988-8
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fibroblastic reticular cells direct the initiation of T cell responses via CD44

Peter Fleming, Harry L. Horsnell, Bagher Golzarroshan, Sheridan Daly et al.
Nature
Cancer Immunotherapy and Biomarkers
article

Fibroblastic reticular cells direct the initiation of T cell responses via CD44

Peter Fleming, Harry L. Horsnell, Bagher Golzarroshan, Sheridan Daly, Christopher E. Andoniou, Stewart D. Lyman, Mohammed H. Abuwarwar, Felix A. Deuss, Richard Berry, Geoffrey R. Hill, Matthew E. Wikström, Iona S. Schuster, Valentina Voigt, Anthony A. Scalzo, Serani L. H. van Dommelen, Scott N. Mueller, Georgia E. G. Neate, Anne L. Fletcher, Riley M. Arnold, Jamie Rossjohn, Xavier Y. X. Sng
article en

Abstract

The movement of dendritic cells and T cells within secondary lymphoid organs is critical for the development of adaptive immune responses<sup>1,2</sup>. Central to this process is the fibroblastic reticular cell (FRC) network, which forms a highly organized conduit system that facilitates the movement of and interactions between dendritic cells and T cells<sup>3-6</sup>. Previous studies have partly characterized how FRCs support these interactions<sup>7,8</sup>. However, the molecular mechanisms that operate under physiological conditions remain unknown. Here we show that the viral protein m11, encoded by the herpesvirus murine cytomegalovirus (CMV), inhibits antiviral immunity by targeting the FRC network and interfering with a critical function of cellular CD44. We found that m11 binds to CD44 and established that m11 perturbs the molecular interactions of CD44 with its natural ligand, hyaluronic acid. The interaction of m11 with CD44 impairs the trafficking of dendritic cells within the spleen, thereby impeding efficient priming of naive T cells and the initiation of antiviral CD8 T cell responses. The targeting of CD44 by CMV reveals CD44 as a molecule that is essential to the functioning of the FRC network and uncovers a previously unrecognized stroma-based mechanism that is critical for the generation of effective T cell responses.

NatureVol. 651(8106)
Lions Eye Institute (AU), The University of Melbourne (AU), QIMR Berghofer Medical Research Institute (AU), Discovery Institute (US), Australian Regenerative Medicine Institute (AU), University of Washington Medical Center (US), Fred Hutch Cancer Center (US), Peter Doherty Institute (AU), AgriBio (AU), CTI BioPharma (Italy) (IT), Monash University (AU), Cardiff University (GB)
Openalex Percentile: Top 81%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.